Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Manuel DE Jesus Escano"'
Autor:
David C. Chen, Liang Qu, Howard Webb, Kirby Qin, Bodie Chislett, Alan Xue, Sari Khaleel, Manuel De Jesus Escano, Eric Chung, Ahmed Adam, Damien Bolton, Marlon Perera
Publikováno v:
Current Urology, Vol 17, Iss 1, Pp 68-76 (2023)
Abstract. Objective. The aim of the study is to investigate improvements in lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH) treated with prostatic Aquablation. Materials and methods. We performed a literature search of cli
Externí odkaz:
https://doaj.org/article/0becff3548834dba9da88fe2adc97a2d
Autor:
David C. Chen, Liang Qu, Howard Webb, Kirby Qin, Bodie Chislett, Alan Xue, Sari Khaleel, Manuel De Jesus Escano, Eric Chung, Ahmed Adam, Damien Bolton, Marlon Perera
Publikováno v:
Current Urology. 17:68-76
Autor:
Carissa Chu, Jessica Chen, Manuel DE Jesus Escano, Karissa Whiting, Irina Ostrovnaya, Song Jiang, Wesley Yip, Sari Khaleel, Andrew Lenis, Timothy Clinton, Goh Alvin, CHA Eugene, Timothy Donahue, Guido Dalbagni, Gopa Iyer, David Solit, Judy Sarungbam, Hikmat AL-Ahmadie, Bernard Bochner, Eugene Pietzak
Publikováno v:
Journal of Urology. 209
Autor:
Wesley Yip, Daniel Sjoberg, Nathan Wong, Manuel de Jesus Escano, Song Jiang, Carissa Chu, Nicole Benfante, Sherri Donat, Harry Herr, Guido Dalbagni, Bernard Bochner, Eugene Cha
Publikováno v:
Journal of Urology. 207
Autor:
Marlon Perera, Benjamin B. Beech, Manuel De Jesus Escano, Caroline Gmelich, Wesley Yip, Stephen A. Boorjian, James A. Eastham
Publikováno v:
Frontiers in Urology. 2
Radical prostatectomy (RP) remains a standard treatment option for clinically localized high-risk prostate cancer. While RP provides excellent local control, patients with high-risk disease remain at considerable risk for recurrence after surgery. Di
Autor:
Carissa Ellen Chu, Manuel De Jesus Escano, Wesley Yip, Song Jiang, Gopa Iyer, Hikmat A. Al-Ahmadie, Alvin C. Goh, Guido Dalbagni, Bernard H. Bochner, David B. Solit, Eugene J. Pietzak
Publikováno v:
Journal of Clinical Oncology. 40:567-567
567 Background: Human epidermal growth factor receptor 2 (HER2) (gene name: ERBB2) is a member of the epidermal growth factor receptor (EGFR) family and when mutated, associated with higher grade and stage of localized bladder cancer. Two HER2-target
Autor:
Hong Truong, Rania Sheikh, Yelena Kemel, Manuel De Jesus Escano, Aliya Khurram, Peter Reisz, Andrew Thomas Lenis, Alvin C. Goh, Eugene K. Cha, Bernard H. Bochner, Gopa Iyer, Jonathan E. Rosenberg, Dean F. Bajorin, David B. Solit, Zsofia Kinga Stadler, Alicia Latham, Kenneth Offit, Maria Isabel Carlo, Jonathan Coleman, Hikmat A. Al-Ahmadie
Publikováno v:
Journal of Clinical Oncology. 40:523-523
523 Background: Despite being a rare cancer, upper tract urothelial carcinoma (UTUC) is the third most common core cancer associated with Lynch syndrome (LS) after colorectal and endometrial cancers. Yet, there is no established guideline to identify